NCT00300664View on ClinicalTrials.gov

A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

April 30, 2005

Conditions

Multiple MyelomaAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome

Interventions

DRUG

Human Growth hormone

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00300664 - A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. | Biotech Hunter | Biotech Hunter